Clinical Trial Update: Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID) [NA]

View source ↗

Summary

The Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID) trial sponsored by the University of California, Los Angeles has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia

Snippet

Sponsor: University of California, Los Angeles | Conditions: Dementia | NA | Status: COMPLETED